BAY32-5915

CAS No. 1571-30-8

BAY32-5915( 8-Hydroxyquinoline-2-carboxylic acid )

Catalog No. M27330 CAS No. 1571-30-8

BAY32-5915 is a selective inhibitor of IKKalpha.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG 36 In Stock
200MG Get Quote In Stock
500MG 78 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BAY32-5915
  • Note
    Research use only, not for human use.
  • Brief Description
    BAY32-5915 is a selective inhibitor of IKKalpha.
  • Description
    BAY32-5915 is a selective inhibitor of IKKalpha.
  • In Vitro
    BAY32-5915 (50-200 μM) has no significant inhibitory effect on NF-κB activity in melanoma cells.
  • In Vivo
    ——
  • Synonyms
    8-Hydroxyquinoline-2-carboxylic acid
  • Pathway
    Immunology/Inflammation
  • Target
    IκB kinase (IKK)
  • Recptor
    PEGs
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1571-30-8
  • Formula Weight
    189.17
  • Molecular Formula
    C10H7NO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (660.78 mM)
  • SMILES
    OC(=O)c1ccc2cccc(O)c2n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
molnova catalog
related products
  • LY2409881 trihydroch...

    LY2409881 trihydrochloride is a novel selective inhibitor of IKK2 with IC50 of 30 nM; IC50 for IKK1 and other common kinases is at least one log higher.

  • Rosiglitazone HCl

    Rosiglitazone HCl is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.

  • Bay 65-1942 hydrochl...

    A potent, selective, ATP-competitive inhibitor of IKKβ kinase with Ki of 2 nM.